Kelly Mahuron
Overview
Explore the profile of Kelly Mahuron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
258
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hernandez M, Fan D, Sandhu J, Mahuron K, Kessler J, Raoof M, et al.
J Surg Oncol
. 2024 Mar;
129(7):1254-1264.
PMID: 38505908
Background And Methods: We characterized colorectal liver metastasis recurrence and survival patterns after surgical resection and intraoperative ablation ± hepatic arterial infusion pump (HAIP) placement. We estimated patterns of recurrence...
2.
Melstrom L, Mahuron K, Sun V
JAMA Surg
. 2024 Mar;
159(5):562.
PMID: 38477896
No abstract available.
3.
Yan Y, Wang D, Mahuron K, Wang X, Lu L, Zhao Z, et al.
Ann Surg Oncol
. 2023 Jul;
30(11):6718-6727.
PMID: 37442910
Background: Esophagojejunostomy after minimally invasive total gastrectomy (MITG) for gastric cancer (GC) is technically challenging. Failure of the esophagojejunal anastomosis can lead to significant morbidity, leading to short- and long-term...
4.
Collins C, Mahuron K, Bongiovanni T, Lancaster E, Sosa J, Wick E
J Surg Educ
. 2020 Aug;
78(2):422-430.
PMID: 32792326
Objective: The COVID-19 pandemic has drastically transformed the healthcare community and medical education across the United States. The aim of this study was to evaluate the impact of COVID-19 on...
5.
Kasai Y, Mahuron K, Hirose K, Corvera C, Kim G, Hope T, et al.
J Surg Oncol
. 2020 Apr;
122(2):204-211.
PMID: 32291778
Background And Objectives: We classified the extent of mesenteric mass (MM) involvement that predicts challenging mesenteric lymph node dissection (mLND) by minimally invasive surgery (MIS) for ileal neuroendocrine tumors (i-NETs)....
6.
Kasai Y, Mahuron K, Hirose K, Corvera C, Kim G, Hope T, et al.
J Surg Oncol
. 2019 Oct;
120(8):1311-1317.
PMID: 31613999
Background And Objectives: Ileal neuroendocrine tumors (i-NETs) frequently metastasize to mesenteric lymph nodes and the liver. Regional lymphadenopathy is associated with desmoplasia of the mesentery forming a large mesenteric mass...
7.
Wang D, Quiros J, Mahuron K, Pai C, Ranzani V, Young A, et al.
Cell Rep
. 2018 Jun;
23(11):3262-3274.
PMID: 29898397
Regulatory T cells (Tregs) are critical for maintaining immune homeostasis, but their presence in tumor tissues impairs anti-tumor immunity and portends poor prognoses in cancer patients. Here, we reveal a...
8.
Loo K, Tsai K, Mahuron K, Liu J, Pauli M, Sandoval P, et al.
JCI Insight
. 2017 Jul;
2(14).
PMID: 28724802
Background: Programmed death 1 (PD-1) inhibition activates partially exhausted cytotoxic T lymphocytes (peCTLs) and induces tumor regression. We previously showed that the peCTL fraction predicts response to anti-PD-1 monotherapy. Here,...